Abstract
Sclerotherapy is a technique used to remove anomalous venous malformations through the injection of a sclerosing agent, classically a liquid, which produces a chemical destruction of the endothelial cells that coat the interior of the vessel. A thrombus is then produced, and the vein is finally transformed into a fibrous thread that ultimately disappears.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Poldervaart MT, Breugem CC, Speleman L, Pasmans S (2009) Treatment of lymphatic malformations with OK-432 (Picibanil): review of the literature. J Craniofac Surg 20(4):1159–1162
Belov S, Loose DA, Weber J (1989) Vascular malformations. Periodica Angiologica, vol 16. Einhorn Presse Verlag, Reinbek, pp 25–27
Mulliken J, Young AE (1988) Vascular birthmarks: hemangiomas and malformations. WB Saunders, Philadelphia
Loose DA (2007) Modern tactics and techniques in the treatment of angiodysplasias of the foot. Chir del Piede 25:1–17
Lee BB, Mattassi R, Loose DA et al (2005) Consensus on controversial issues in contemporary diagnosis and management of congenital vascular malformation: Seoul communication. Int J Angiol 13:182–192
Loose DA (2007) Surgical management of venous malformations. Phlebology 22:276–282
Yakes WF, Luethke JM, Parker SH et al (1990) Ethanol embolization of vascular malformations. Radiographics 10:787–796
De Lorimier AA (1995) Sclerotherapy for venous malformations. J Pediatr Surg 30:188–194
Claesson G, Kuyelenstierna R (2002) OK-432 therapy for lymphatic malformation in 32 patients (28 children). Int J Pediatr Otorhinolaryngol 65:1–6
Villavicencio JL (2001) Primum non nocere: is it always true? The use of absolute ethanol in the management of congenital vascular malformations. J Vasc Surg 33:904–906
Belov S (1998) Late results in the treatment of vascular malformations. Int Angiol 7:136–143
Cabrera J, Cabrera J Jr, García-Olmedo MA (1997) Elargisemcnt des limites de la sclerotherapie: Nouveaux produits sclerosants. Phlebologie 2:181–188
Cabrera J, Cabrera J Jr, García-Olmedo MA (2000) Treatment of varicose long saphenous veins with sclerosant in microfoam form: long-term outcomes. Phlebology 15:19–23
Cabrera J, Cabrera J Jr (1997) BTG International Limited Assignee. Injectable microfoam containing a sclerosing agent. US patent 5676962
Bikerman JJ (1973) Foams. Springer, New York
Puig S, Casati B, Staudenherz A, Paya K (2005) Vascular low-flow malformations in children: current concepts for classification, diagnosis and therapy. Eur J Radiol 53(1):35–45
Cabrera J, Cabrera J Jr, García Olmedo MA, Redondo P (2003) Treatment of venous malformations with sclerosant in microfoam form. Arch Dermatol 139:1409–141
Belov S (1990) Classification of congenital vascular defects. Int Angiol 9:141–146
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2015 Springer-Verlag Italia
About this chapter
Cite this chapter
Garrido, J.C., Rubia, M.V., Loose, D.A. (2015). Sclerotherapy in Vascular Malformations with Polidocanol Foam. In: Mattassi, R., Loose, D., Vaghi, M. (eds) Hemangiomas and Vascular Malformations. Springer, Milano. https://doi.org/10.1007/978-88-470-5673-2_34
Download citation
DOI: https://doi.org/10.1007/978-88-470-5673-2_34
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5672-5
Online ISBN: 978-88-470-5673-2
eBook Packages: MedicineMedicine (R0)